Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range.
about
Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancerComprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countriesProstate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaProspective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1.Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literatureThe prostate health index selectively identifies clinically significant prostate cancer.CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis.Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonographyDiagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis.Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.Clarifying the PSA grey zone: The management of patients with a borderline PSA.Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China.Prostate Health Index density improves detection of clinically significant prostate cancer.The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort.Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study.Prostate cancer in Asia: A collaborative report.Stability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions
P2860
Q26824913-6B522E94-EE99-41AD-B803-B2D1F7D21FDCQ26996461-AEA5D52C-D2A8-46E4-A7B3-1FABF5B2BACBQ28085419-D995DAD6-F7CC-419F-BBA8-B6980C5029ACQ33668692-EF5617D3-12EE-4CC8-8BB8-6540A355687FQ33911725-8476C6F7-653E-44EB-9561-26DD43976863Q35498981-A8BF8A83-2CEA-4EA7-84CE-037E227FC7F6Q36148171-4C288F41-5830-443B-8E77-D26EF6292B43Q37113204-0B19B6C4-DE4D-4046-BF30-FF4AFCD40D32Q37738370-CBEC4FBC-C341-49D6-BCE2-9730B7EE07DEQ38241107-556CAC14-EC43-4770-AD4E-4811389357C7Q38394519-9F2C4845-8991-43C9-BB5F-F15A9CEE0E28Q38965360-1A794B97-840D-479D-85AE-2D8E83941B1DQ40140207-8EF8963E-4DD8-4225-80DE-77BF8E304937Q40433157-F54DFBFE-8853-4DA1-B3DB-B5E6B0BD4144Q41878045-8577B1B0-8C8D-4088-B974-3FBC921D6C8FQ52679257-25E3F08D-00F4-4E6F-A0F7-F7F8D0D5899CQ55216204-C88888C3-F874-46A2-BDF3-EF4045A45498Q57145337-035706B9-C833-4AFB-AE9F-1F079BD70AC6
P2860
Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@en
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@nl
type
label
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@en
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@nl
prefLabel
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@en
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@nl
P2093
P2860
P1476
Diagnostic significance of [-2 ...... A in the 2.0-10.0 ng/mL range.
@en
P2093
Hidekazu Koike
Hiroshi Matsui
Kazuhiro Suzuki
Kazuto Ito
Mai Miyakubo
Yasuhiro Shibata
Yoshitaka Sekine
P2860
P2888
P304
P356
10.1007/S00345-012-0927-9
P577
2012-08-18T00:00:00Z
P6179
1002866386